Categories
CANNABIS Food Processing News

House Bill Would Legalize CBD Nationally

Cannabis

House Bill Would Legalize CBD Nationally

By Dave Fusaro, Editor in Chief

Feb 01, 2020

Some members of Congress appear to be losing patience with the FDA’s reluctance to legalize cannabidiol (CBD). On Jan. 13, a bill was introduced to amend the Federal Food, Drug and Cosmetic Act (FDCA) to include hemp-derived CBD as a dietary supplement.

House Agriculture Committee Chairman Collin Peterson (D-Minn.) introduced House Bill 5587, described by lawyers at Ritter Spencer PLLC as “a simple, three-page bill with the primary objective of including hemp-derived CBD as a dietary supplement … to be marketed and sold in interstate commerce with adherence to the Dietary Supplement Health and Education Act (DSHEA).”

One of the reasons the FDA has dragged its feet on legalizing CBD, according to some observers, is its adherence to the FDCA, which prohibits the introduction into interstate commerce of a food or dietary supplement ingredient that was first studied as a pharmaceutical drug. Because CBD is the key ingredient in Epidiolex, a drug for the treatment of seizures, the FDA maintains it cannot approve CBD for use in a food, beverage, or cosmetic.

“Though we do not necessarily anticipate this bill to pass, it will most likely serve as an effective tool to goad the FDA into action,” said a statement from Ritter Spencer. “It is at least a small step forward toward fixing the FDA issues.”

Source: House Bill Would Legalize CBD Nationally






 

Categories
CANNABIS Investing

Profit Trends – KushCo.

Marijuana legalization is spreading – not just across the U.S., but across the globe.

That creates a lot of opportunities up and down the supply chain, as well as on the creative side.

And there’s one company involved in legal cannabis more than any other: KushCo Holdings (OTC: KSHB).

KushCo has a diverse footprint across a variety of product segments. It provides packaging, labeling, papers, marketing, solvents, hydrocarbons and vaporizer technology.

The company is active in every legal jurisdiction in North America and distributes in more than 20 countries.

Since 2010, KushCo has sold more than 1 billion units and provides services to more than 6,000 medical and adult-use growers across Europe, North America and South America.

That’s why we welcomed KushCo CEO Nick Kovacevich as our guest for a candid interview.

He explains what he thinks investors are missing about the company, as well as why KushCo’s business is more protected than many know. As he says, it’s far more than just a packaging company.

Kovacevich also shares the total addressable retail market that he estimates KushCo can capture. And he discusses the opportunities the company sees in CBD and beyond.

Right now, KushCo may be trading closer to its 52-week lows than highs due to pressure on the greater cannabis industry. But believe me when I say this is one confident CEO.

And that’s what we like to see.

Here’s to high returns,

Matthew

Watch Video for interview: Profit Trends